Login to Your Account

Chiron Settles With Roche For $78M, Licenses IP To InterMune

By Karen Pihl-Carey

Tuesday, September 14, 2004
Chiron Corp. finalized a settlement agreement with F. Hoffmann-La Roche Ltd. concerning an HIV patent late last week, then announced Monday an agreement to provide InterMune Inc. with its hepatitis C targets. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription